Skip to main content

Table 3 Subgroup analyses of primary outcomes

From: Fecal microbiota transplantation versus glucocorticoids for the induction of remission in mild to moderate ulcerative colitis

Subgroups, n (%)

FMT group (n = 62)

GCs group (n = 60)

p value

Age

 < 60

29 (59.2) (n = 49)

22 (52.4) (n = 42)

0.51

 ≥ 60

5 (38.5) (n = 13)

7 (38.9) (n = 18)

0.64

Gender

 Male

26 (59.1) (n = 44)

22 (51.2) (n = 43)

0.46

 Female

8 (44.4) (n = 18)

7 (41.2) (n = 17)

0.56

Disease extent

 E1, Proctitis

9 (69.2) (n = 13)

7 (63.6) (n = 11)

0.56

 E2, Left-sided colitis

13 (54.2) (n = 24)

14 (51.9) (n = 27)

0.87

 E3, Pancolitis

12 (48.0) (n = 25)

8 (36.4) (n = 22)

0.42

Duration of disease, (years)

 ≤ 1

19 (55.9) (n = 34)

12 (54.5) (n = 22)

0.92

 > 1

15 (53.6) (n = 28)

17 (44.7) (n = 38)

0.48

  1. FMT fecal microbiota transplantation, GCs glucocorticoids